The potential role of basophilic leukocytes and mast cellsGÖTZE, O.Nephrology, dialysis, transplantation (Print). 1994, Vol 9, pp 57-59, issn 0931-0509, SUP2Article

HUMAN MONOCYTE SPREADING INDUCED BY FACTOR B OF THE ALTERNATIVE PATHWAY OF COMPLEMENT ACTIVATIONSUNDSMO JS; GOTZE O.1980; CELL. IMMUNOL.; USA; DA. 1980; VOL. 52; NO 1; PP. 1-17; BIBL. 68 REF.Article

HUMAN MONOCYTE SPREADING INDUCED BY FACTOR BB OF THE ALTERNATIVE PATHWAY OF COMPLEMENT ACTIVATION. A POSSIBLE ROLE FOR C5 IN MONOCYTE SPREADINGSUNDSMO JS; GOTZE O.1981; J. EXP. MED.; ISSN 0022-1007; USA; DA. 1981; VOL. 154; NO 3; PP. 763-777; BIBL. 73 REF.Article

THE ALTERNATIVE PATHWAY OF COMPLEMENT ACTIVATION.GOTZE O; MULLER EBERHARD HJ.1976; ADV. IN IMMUNOL.; U.S.A.; DA. 1976; VOL. 24; PP. 1-35; BIBL. 9 P.Article

ALTERNATIVE PATHWAY OF COMPLEMENT: RECRUITMENT OF PRECURSOR PROPERDIN BY THE LABILE C3/C5 CONVERTASE AND THE POTENTIATION OF THE PATHWAY.MEDICUS RG; GOTZE O; MULLER EBERHARD HJ et al.1976; J. EXPER. MED.; U.S.A.; DA. 1976; VOL. 144; NO 4; PP. 1076-1093; BIBL. 2 P.Article

UEBER DIE LEBENSERWARTUNG VON PATIENTEN MIT ZIRKULATIONSSTOERUNGEN AM HINTEREN BULBUSABSCHNITTECKARDT C; GOTZE O; UTERMANN D et al.1983; OPHTHALMOLOGICA (BASEL); ISSN 0030-3755; CHE; DA. 1983; VOL. 187; NO 1; PP. 34-42; ABS. ENG/FRE; BIBL. 16 REF.Article

NEPHRITIC FACTOR. ITS STRUCTURE AND FUNCTION AND ITS RELATIONSHIP TO INITIATING FACTOR OF THE ALTERNATIVE PATHWAY.SCHREIBER RD; GOTZE O; MULLER EBERHARD HJ et al.1976; SCAND. J. IMMUNOL.; NORWAY; DA. 1976; VOL. 5; NO 6-7; PP. 705-713; BIBL. 24 REF.Article

NEPHRITIC FACTOR: DESCRIPTION OF A NEW QUANTITATIVE ASSAY AND FINDINGS IN GLOMERULONEPHRITIS.BORDER WA; WILSON CB; GOTZE O et al.1976; KIDNEY INTERNATION.; GERM.; DA. 1976; VOL. 10; NO 4; PP. 311-318; ABS. FR.; BIBL. 1 P. 1/2Article

ALTERNATIVE PATHWAY OF COMPLEMENT: DEMONSTRATION AND CHARACTERIZATION OF INITIATING FACTOR AND ITS PROPERDIN-INDEPENDENT FUNCTION.SCHREIBER RD; GOTZE O; MULLER EBERHARD HJ et al.1976; J. EXPER. MED.; U.S.A.; DA. 1976; VOL. 144; NO 4; PP. 1062-1075; BIBL. 2 P.Article

Characterization of physiologic breakdown products of the complement fragment BaOPPERMANN, M; GÖTZE, O.Molecular immunology. 1994, Vol 31, Num 4, pp 307-314, issn 0161-5890Article

Plasma clearance of the human C5a anaphylatoxin by binding to leucocyte C5a receptorsOPPERMANN, M; GÖTZE, O.Immunology (Oxford). 1994, Vol 82, Num 4, pp 516-521, issn 0019-2805Article

The isolation of B lymphocytes from human peripheral blood using antibodies coupled to paramagnetic particles and rosetting techniquesHEBELL, T; GÖTZE, O.Journal of immunological methods. 1989, Vol 123, Num 1, pp 283-291, issn 0022-1759Article

PROPERDIN- AND NEPHRITIC FACTOR-DEPENDENT C3 CONVERTASES: REQUIREMENT OF NATIVE C3 FOR ENZYME FORMATION AND THE FUNCTION OF BOUND C3B AS PROPERDIN RECEPTOR. = C3 CONVERTASES DEPENDANT DE LA PROPERDINE ET DU FACTEUR NEPHRITIQUE: NECESSITE DE C3 NATIF POUR LA FORMATION DE L'ENZYME, ET LA FONCTION DU C3B LIE COMME RECEPTEUR DE PROPERDINESCHREIBER RD; MEDICUS RG; GOTZE O et al.1975; J. EXPER. MED.; U.S.A.; DA. 1975; VOL. 142; NO 3; PP. 760-772; BIBL. 1 P. 1/2Article

REVERSIBLE ACTIVATION OF PRIACTIVATOR (FACTOR B) OF THE ALTERNATIVE PATHWAY WITHOUT CLEAVAGE OF THE MOLECULE.DAY NK; SCHREIBER RD; GOTZE O et al.1976; SCAND. J. IMMUNOL.; NORWAY; DA. 1976; VOL. 5; NO 6-7; PP. 715-720; BIBL. 16 REF.Article

A MOLECULAR CONCEPT OF THE PROPERDIN PATHWAYMEDICUS RG; SCHREIBER RD; GOTZE O et al.1976; PROC. NATION. ACAD. SCI. U.S.A.; U.S.A.; DA. 1976; VOL. 73; NO 2; PP. 612-616; BIBL. 28 REF.Article

A FLUORESCENT ASSAY FOR COMPLEMENT ACTIVATIONCAPORALE LH; SUNG SUK GABER; KELL W et al.1981; J. IMMUNOL.; ISSN 0022-1767; USA; DA. 1981; VOL. 126; NO 5; PP. 1963-1965; BIBL. 18 REF.Article

A novel ELISA for the assessment of classical pathway of complement activation in vivo by measurement of C4-C3 complexesZWIRNER, J; DOBOS, G; GÖTZE, O et al.Journal of immunological methods. 1995, Vol 186, Num 1, pp 55-63, issn 0022-1759Article

A novel ELISA for the evaluation of the classical pathway of complementZWIRNER, J; WITTIG, A; KREMMER, E et al.Journal of immunological methods. 1998, Vol 211, Num 1-2, pp 183-190, issn 0022-1759Article

Die Anwendung eines C1-Inhibitorkonzentrats zur präoperativen Kurzzeitprophylaxe bei zwei Patienten mit hereditärem Angioödem = Preoperative short-term prophylaxis with C1 inhibitor concentrate in two patients with hereditary angioneurotic oedemaMOHR, M; POLLOK-KOPP, B; GÖTZE, O et al.Der Anaesthesist (Berlin. Print). 1996, Vol 45, Num 7, pp 626-630, issn 0003-2417Article

Terminal complement pathway activation and low lysis inhibitors in rheumatoid arthritis synovial fluidHØGASEN, K; MOLLNES, T. E; HARBOE, M et al.Journal of rheumatology. 1995, Vol 22, Num 1, pp 24-28, issn 0315-162XArticle

HUMAN COMPLEMENT METABOLISM: AN ANALYSIS OF 144 STUDIESRUDDY S; CARPENTER CB; CHIN KW et al.1975; MEDECINE; U.S.A.; DA. 1975; VOL. 54; NO 2; PP. 165-178; BIBL. 28REF.Article

CD11b and CD11c antigens are rapidly increased on human natural killer cells upon activationWERFEL, T; WITTER, W; GOTZE, O et al.The Journal of immunology (1950). 1991, Vol 147, Num 7, pp 2423-2427, issn 0022-1767Article

PARTIAL LIPODYSTROPHY, C3 NEPHRITIC FACTOR AND CLINICALLY INAPPARENT MESANGIOCAPILLARY GLOMERULONEPHRITIS.BENNETT WM; BARDANA EJ; WUEPPER K et al.1977; AMER. J. MED.; U.S.A.; DA. 1977; VOL. 62; NO 5; PP. 757-760; BIBL. 14 REF.Article

Increase by anaphylatoxin C5a of glucose output in perfused rat liver via prostanoids derived from nonparenchymal cells : Direct action of prostaglandins and indirect action of thromboxane A₂ on hepatocytesSCHIEFERDECKER, H. L; PESTEL, S; PÜSCHEL, G. P et al.Hepatology (Baltimore, Md.). 1999, Vol 30, Num 2, pp 454-461, issn 0270-9139Article

Significant reduction of factor D and immunosuppressive complement fragment Ba by hemofiltrationKAISER, J. P; OPPERMANN, M; GÖTZE, O et al.Blood purification. 1995, Vol 13, Num 6, pp 314-321, issn 0253-5068Conference Paper